Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia

IMPORTANCE: Although concerns exist regarding a potential increased risk of cardiovascular events for smoking cessation pharmacotherapies, there is general consensus that any increased risk associated with their use would be outweighed by the benefits of smoking cessation; thus, clinical guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales: Havard, Alys, Choi, Stephanie K. Y., Pearson, Sallie-Anne, Chow, Clara K., Tran, Duong T., Filion, Kristian B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630569/
https://www.ncbi.nlm.nih.gov/pubmed/34842922
http://dx.doi.org/10.1001/jamanetworkopen.2021.36372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630569/
https://www.ncbi.nlm.nih.gov/pubmed/34842922
http://dx.doi.org/10.1001/jamanetworkopen.2021.36372

Ejemplares similares